Company: DRTSW
Filing Date: 2025-03-12
Form Type: 20-F
Source: 0001213900-25-023187
Chunk: 91

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-03-12
Form: 20-F
Item: Item 3
Chunk 91
---
 our directors                                     

  our Articles generally require                                                                                                                

  our Articles do not permit                                                                                                                

  our Articles provide that director                  
  vacancies may be filled by our board of directors.  
 ──────────────────────────────────────────────────────

Furthermore, under the Encouragement
of Research, Development and Technological Innovation in the Industry Law 5744-1984 (formerly known as the Law for the Encouragement of
Research and Development in Industry 5744-1984), and the regulations and guidelines promulgated thereunder, or the Innovation Law, to
which we are subject due to our receipt of grants from the Israel Innovation Authority, or IIA (formerly known as the Office of the Chief
Scientist of the Ministry of Economy and Industry, or the OCS), a recipient of IIA grants such as us must report to the IIA regarding
any change of control of the company or regarding any change in the holding of the means of control of the company which results in any
non-Israeli citizen or entity becoming an “interested party”, as defined in the Innovation Law, in the company, and in the
latter event, the non-Israeli citizen or entity will be required to execute an undertaking in favor of IIA, in a form prescribed by IIA,
acknowledging the restrictions imposed by such law and agreeing to abide by its terms.

Further, Israeli tax considerations
may make potential transactions undesirable to us or to some of our shareholders whose country of residence does not have a tax treaty
with Israel granting tax relief to such shareholders from Israeli tax. See the section titled “Certain Material Israeli Tax Considerations-Taxation
of Our shareholders.”

We do not intend to pay dividends for the
foreseeable future. Accordingly, you may not receive any return on investment unless you sell your ordinary shares for a price greater
than the price you paid for such shares.

We have never declared or
paid any cash dividends on our shares. We currently intend to retain all available funds and any future earnings for use in the operation
of our business and do not anticipate paying any dividends on our ordinary shares in the foreseeable future. Consequently, you may be
unable to realize a gain on your investment except by selling such shares after price appreciation, which may never occur.

Our board of directors has
sole discretion whether to pay dividends. If our board of directors decides to pay dividends, the form, frequency, and amount will depend
upon our future, operations and earnings, capital requirements